PROGRAM

The Program is designed to offer plenary and interactive sessions along with Free Oral and Poster presentations.  This is and overview and is subject to change.

Keynote Lectures

Pattern Recognition and Cell Signaling in Sepsis

What is New in Sepsis?

The Role of Acute Phase Reactants in Sepsis

Sepsis Therapy in the ICU: evidence based medicine? - Interactive  Sessions

Early Goal Directed Therapy

Corticosterioids

Glucose Control

Fluids and Pressors

The Surviving Sepsis Campaign in Spain

New Developments in Sepsis Care

Rapid Identification of Pathogens

Rapid Monitoring of Immune Response

Pharmacogenomics

Meet the Experts

How to Feed a Sepsis Patient

The Pre-Clinical Path to Develop a Sepsis Drug

How to Treat Coagulation Disorders and Bleeding in Sepsis

How to Design a Sepsis Trial

How to Ventilate a Patient

New Therapeutic Targets in Sepsis

TREM-1

HMGB1

RAGE

C5a

Current Sepsis Trials I: Immunomodulatory Agents

TLR4 Inhibitors and Statins

Current Sepsis Trials II: Anticoagulants

Recombinant Tissue Factor Pathway Inhibitor

Recombinant Activated Protein C

Heparin and Recombinant Soluble Thrombomodulin

Common Sources of Sepsis

Community-acquired Pneumonia

Ventilator-associated Pneumonia

Pretonitis

Sepsis Induced Failure of Cellular and Organ Function- Interactive Session

Lung Injury

Renal Failure

Metabolic Failure

Apoptosis and Repair

Specific Pathogens: how do they cause sepsis? - Interactive Sessions

Candida albicans

MRSA

Burkholderia pseudomallei (melioidosis)

Streptococcus pyogenes